Rimonabant induces cell cycle arrest and programmed cell death in leukemia cell lines by a mechanism unlikely to be CB1R-dependent due to a low expression of CB1R in the cell lines used (U937 and Jurkat cells) (Gallotta et al., 2010). Here, CNR1 is linked to leukemia.